Life AI Net
Start
Archiv
Rechner
Verzeichnis
Newsletter
Hot
Anmelden
Deutsch
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Start
Archiv
Rechner
Verzeichnis
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Anmelden
Start
Archiv
Rechner
Verzeichnis
More
Live
Lonza News
Acetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com
Thermo Fisher
Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory
10x Genomics Blog
10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
FierceBiotech
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises
FierceBiotech
Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset
FierceBiotech
Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
Roche Media
Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce Biotech
Lonza News
Project Hope Foundation receives $50K donation from Lonza Capsugel - Greenville Journal
Harvard Bioscience
Harvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock Titan
FierceBiotech
Pulnovo Medical scores $100M in finance round led by Medtronic
Lonza News
Acetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com
Thermo Fisher
Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory
10x Genomics Blog
10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
FierceBiotech
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises
FierceBiotech
Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset
FierceBiotech
Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
Roche Media
Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce Biotech
Lonza News
Project Hope Foundation receives $50K donation from Lonza Capsugel - Greenville Journal
Harvard Bioscience
Harvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock Titan
FierceBiotech
Pulnovo Medical scores $100M in finance round led by Medtronic
Archiv
Suchen
Suchen
Aktuell
Älteste
Löschen
@BioWorld
Gesamt
1062
Quelle
BioWorld
Suche
--
BioWorld
4. März 2026
Moderna to pay up to $2.25B to settle COVID-19 patents case
BioWorld
4. März 2026
Moderna to pay up to $2.25B to settle COVID-19 patents case
BioWorld
3. März 2026
GSK nabs two Frontier Biotech siRNA assets in $1B deal
BioWorld
3. März 2026
Wave of deals lifts large-cap biopharma stocks
BioWorld
3. März 2026
US taking a closer look at China biotech subsidies
BioWorld
3. März 2026
Systimmune’s iza-bren hits phase III breast cancer goals in China
BioWorld
3. März 2026
Returning to pulmonary hypertension, GSK buys 35Pharma
BioWorld
3. März 2026
Financings for March 3, 2026
BioWorld
3. März 2026
In the clinic for March 3, 2026
BioWorld
3. März 2026
Other news to note for March 3, 2026
BioWorld
3. März 2026
Regulatory actions for March 3, 2026
BioWorld
2. März 2026
Appointments and advancements for March 2, 2026
BioWorld
2. März 2026
Financings for March 2, 2026
BioWorld
2. März 2026
In the clinic for March 2, 2026
BioWorld
2. März 2026
Other news to note for March 2, 2026
BioWorld
2. März 2026
Regulatory actions for March 2, 2026
BioWorld
2. März 2026
Uniqure falls as FDA demands new trial for Huntington’s gene therapy
BioWorld
2. März 2026
Med-tech outlook 2026: exits, financings, headwinds
Zurück
20 / 59
Weiter